Strata Skin Sciences (SSKN) Projected to Post Quarterly Earnings on Wednesday

Strata Skin Sciences (NASDAQ:SSKN) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, August 13th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $8.56 million for the quarter.

Strata Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Wednesday, May 14th. The medical device company reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.02). The firm had revenue of $6.81 million for the quarter, compared to the consensus estimate of $7.28 million. Strata Skin Sciences had a negative return on equity of 138.22% and a negative net margin of 27.22%. On average, analysts expect Strata Skin Sciences to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Strata Skin Sciences Trading Up 5.1%

Shares of NASDAQ SSKN opened at $1.87 on Tuesday. The company’s fifty day moving average is $2.22 and its 200-day moving average is $2.50. The stock has a market cap of $7.80 million, a price-to-earnings ratio of -0.82 and a beta of 0.66. Strata Skin Sciences has a twelve month low of $1.78 and a twelve month high of $3.79. The company has a quick ratio of 0.87, a current ratio of 1.05 and a debt-to-equity ratio of 5.71.

Strata Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.